Search
news › biological-e-limited-to-begin-phase-iii-clinical-trials-with-baylor-and-texas-childrens-vaccine
… E. Limited (BE), an Indian vaccine and pharmaceutical company, announced that it has completed the Phase I/II … vaccine candidate in India and received the approval to start the Phase III clinical trial from the Central Drugs … Development at Baylor College of Medicine and in-licensed to BE by BCM Ventures . “Having our Texas Children’s and …
healthcare › clinical-trials › h-48387
… study in Parkinson's disease patients with dyskinesia to assess the efficacy and safety/tolerability of fixed dose combinations of JM-010 and its individual components. … The purpose of this study, which involved research, is to determine if investigational treatment, JM-010, is safe …
healthcare › clinical-trials › h-41067
… antibodies are antibodies which have been engineered to recognize and bind to a specific type of protein. RO7046015 binds to a protein called alpha synuclein, which is found in the … PASADENA: A Study to Evaluate Intravenous RO7046015 (PRX002) in Participants …
news › nci-nobel-laureat-varmus-commencement-2013
… The commencement ceremony for graduating M.D. and Ph.D. students … Biomedical Sciences at Baylor College of Medicine. NCI Director Dr. Harold Varmus, the co-recipient of the Nobel Prize … this year’s commencement address. Varmus was named director of the National Cancer Institute in 2010 after serving …
healthcare › clinical-trials › h-49062
… multicenter, randomized, controlled pivotal trial to evaluate the safety and effectiveness of transcatheter … with the Edwards Pascal Transcatheter valve repair system compared to abbott mitraclip in patients with mitral regurgitation. … A study to evaluate transcatheter mitral valve repair with the …
news › trish-to-study-spaceflight-effects-on-genome-and-nervous-system-on-axiom-spaces-ax-3-mission
… and performance research projects during Axiom Space’s upcoming Axiom Mission 3 (Ax-3) to the International Space Station (ISS), scheduled to launch in 2024. TRISH is a consortium led by Baylor … TRISH to study spaceflight effects on genome and nervous system on …
news › dr-maria-elena-bottazzi-dr-teresa-a-davis-elected-to-the-national-academy-of-medicine
… Tropical Medicine at Baylor College of Medicine and co-director of the Texas Children's Hospital Center for Vaccine … Center at Baylor and Texas Children’s, have been elected to the National Academy of Medicine . They are among 90 … have demonstrated outstanding professional achievement and commitment to service. “Drs. Bottazzi and Davis are leaders …
healthcare › clinical-trials › h-55239
… Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major … The purpose of this study is to evaluate the safety, efficacy, and maintenance of effect …
healthcare › clinical-trials › h-53299
… is a next-generation small molecule cardiac myosin inhibitor being developed as a chronic, oral treatment for … hypertrophic cardiomyopathy (HCM). Aficamten is designed to reduce the hypercontractility that underlies the … and addressing the fundamental cause of this sarcomeric disease. This is the second Phase 3 trial of …
healthcare › clinical-trials › h-54042
… normal daily activities. SAGE-718 is a unique modulator (regulator of activity) of N-methyl-D-aspartate (NMDA) receptors. NMDA receptors are a type of protein with an important … A study of long-term safety and tolerability of Sage-718 in participants with Huntington's …